This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome

Brendan T. Carroll, MD; Joseph W. Y. Lee, MRCPsych, FRANZCP

Published: December 15, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We read the article by Ananth et al.1 on neuroleptic malignant syndrome (NMS) and atypical antipsychotic drugs with great interest. We thank them for their review of 68 cases drawn from the medical literature. They identified some of the major risk factors for NMS associated with atypical antipsychotics, including the male gender, diagnosis of schizophrenia and other psychoses, mental retardation, and concurrent physical illness.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Neuroleptic Malignant Syndrome , Side Effects-Medication

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Insights

LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...

Read More...